International Flavors & Fragrances Health & Biosciences — Restructuring Charges decreased by 50.0% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $3.00M to $2.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests active cost-cutting or structural transformation, while a decrease indicates a more stable operational environment.
Represents non-recurring costs associated with reorganizing, downsizing, or streamlining operations within the Health &...
Commonly reported as 'Restructuring' or 'Special Items' by industrial and specialty chemical peers.
iff_segment_health_biosciences_restructuring_charges| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $1.00M | $0.00 | $1.00M | $1.00M | $0.00 | $10.00M | $1.00M | $1.00M | $1.00M | $1.00M | $0.00 | $0.00 | $3.00M | $5.00M | $4.00M | $2.00M |
| QoQ Change | — | -75.0% | -100.0% | — | +0.0% | -100.0% | — | -90.0% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | +66.7% | -20.0% | -50.0% |
| YoY Change | — | — | — | -75.0% | +0.0% | — | — | +0.0% | +0.0% | — | -90.0% | -100.0% | -100.0% | +200.0% | — | — | -33.3% |